Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling.
about
Hepatocyte Growth Factor, a Key Tumor-Promoting Factor in the Tumor Microenvironment.The role of type II transmembrane serine protease-mediated signaling in cancer.Targeting the tumor-promoting microenvironment in MET-amplified NSCLC cells with a novel inhibitor of pro-HGF activation.The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancerEngineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein.
P2860
Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Inhibition of pro-HGF activati ...... k oncogenic HGF/MET signaling.
@en
Inhibition of pro-HGF activati ...... k oncogenic HGF/MET signaling.
@nl
type
label
Inhibition of pro-HGF activati ...... k oncogenic HGF/MET signaling.
@en
Inhibition of pro-HGF activati ...... k oncogenic HGF/MET signaling.
@nl
prefLabel
Inhibition of pro-HGF activati ...... k oncogenic HGF/MET signaling.
@en
Inhibition of pro-HGF activati ...... k oncogenic HGF/MET signaling.
@nl
P2093
P2860
P356
P1433
P1476
Inhibition of pro-HGF activati ...... k oncogenic HGF/MET signaling.
@en
P2093
Benjamin Y Owusu
Larry J Ross
Lidija Klampfer
Namita Bansal
Phanindra K M Venukadasula
Robert A Galemmo
Sanjay Goel
Troy E Messick
P2860
P304
29492-29506
P356
10.18632/ONCOTARGET.8785
P407
P577
2016-04-18T00:00:00Z